Ranson Criteria and BISAP Score: Acute Pancreatitis Severity, 2012 Revised Atlanta Classification (Modified Marshall), and Balthazar CTSI

The Ranson Criteria (Ranson et al., 1974) and the Bedside Index for Severity in Acute Pancreatitis (BISAP Score — Wu et al., 2008) are the two benchmark clinical prognostic rules used to predict early organ failure and in-hospital mortality in patients hospitalized with acute pancreatitis. Across emergency departments utilizing AI scribes for emergency medicine, intensive care units, and clinical trials built on electronic clinical outcome assessment (eCOA) and HL7 FHIR Observation pipelines, clinicians pair early 24-hour prognostic scoring (BISAP) with the structural 2012 Revised Atlanta Classification (Banks et al., 2013)—which defines organ failure via the Modified Marshall Scoring System—and morphological grading on contrast-enhanced computed tomography via the Balthazar CT Severity Index (CTSI).

Why Has the 5-Point Bedside BISAP Score (BUN >25, Impaired Mental Status, SIRS, Age >60, Pleural Effusion Within 24 Hours) Largely Replaced the 48-Hour 11-Item Ranson Criteria?

Introduced in 1974 by surgeon John H. C. Ranson and colleagues, the 11-item Ranson Criteria were the first validated prognostic tool for acute pancreatitis. However, Ranson’s model has three major operational disadvantages in modern acute care: (1) it requires 48 full hours of hospitalization before the score can be completed (missing the critical first 24-hour window for aggressive lactated Ringer’s resuscitation and ICU triage), (2) it uses different laboratory cutoffs for non-gallstone (alcoholic) vs. gallstone pancreatitis, and (3) several of its 48-hour parameters (such as base deficit, arterial PaO₂, and estimated fluid sequestration) are not routinely measured in stable floor patients.

To overcome these barriers, Bechien U. Wu, Peter A. Banks, and colleagues (Gut, 2008) derived and validated the 5-point BISAP Score across 17,922 cases and 18,256 validation cases from 212 hospitals. Calculated entirely within the first 24 hours of admission, BISAP achieves predictive accuracy for in-hospital mortality (AUROC 0.82) equivalent to APACHE II and Ranson Criteria with just 5 routine bedside variables:

BISAP Acronym (0–5 Points Within First 24 Hours; Wu et al., 2008)

11-Item Ranson Criteria — Non-Gallstone vs. [Gallstone] Cutoffs (Ranson et al., 1974 / 1979)

B — BUN > 25 mg/dL (> 8.92 mmol/L) (+1 point) I — Impaired mental status (Glasgow Coma Scale [GCS] < 15, disorientation, lethargy, somnolence, or stupor) (+1 point) S — SIRS present (≥ 2 of 4 Systemic Inflammatory Response Syndrome criteria: Temp <36°C or >38°C; HR >90 bpm; RR >20/min or PaCO2 <32 mmHg; WBC <4,000 or >12,000/µL or >10% bands) (+1 point) A — Age > 60 years (+1 point) P — Pleural effusion detected on chest X-ray, ultrasound, or CT (+1 point) BISAP Mortality Stratification: • 0–2 points (Low Risk): In-hospital mortality < 2% (0 pts = 0.1%–0.2%; 1 pt = 0.5%–0.7%; 2 pts = 1.6%–2.1%) • ≥ 3 points (High Risk): Mortality rises sharply (3 pts = 5.3%–8.3%; 4 pts = 12.7%–19.3%; 5 pts = 22.5%–26.7%), with high risk of persistent organ failure and pancreatic necrosis.

At Admission (5 Items — 1 point each): Age: > 55 years [Gallstone: > 70 years] WBC count: > 16,000 /µL [Gallstone: > 18,000 /µL] Blood Glucose: > 200 mg/dL [Gallstone: > 220 mg/dL] Serum LDH: > 350 IU/L [Gallstone: > 400 IU/L] Serum AST (SGOT): > 250 IU/L [Gallstone: > 250 IU/L] At 48 Hours After Admission (6 Items — 1 point each): Hematocrit fall: > 10 percentage points [Gallstone: > 10%] BUN increase: > 5 mg/dL [Gallstone: > 2 mg/dL] Serum Calcium: < 8.0 mg/dL [Gallstone: < 8.0 mg/dL] Arterial PaO2: < 60 mmHg [Gallstone: omitted in 10-item gallstone variant] Base Deficit: > 4 mEq/L [Gallstone: > 5 mEq/L] Estimated Fluid Sequestration: > 6 Liters [Gallstone: > 4 Liters] Ranson Mortality: 0–2 pts (~1%–2% mortality); 3–4 pts (~15%); 5–6 pts (~40%); ≥ 7 pts (~100%).

How Does the 2012 Revised Atlanta Classification Stratify Acute Pancreatitis Into Mild, Moderately Severe, and Severe Using the Modified Marshall Organ Failure Score?

While BISAP and Ranson are predictive scores at admission, the actual clinical severity of an episode of acute pancreatitis is defined by the 2012 Revised Atlanta Classification (Banks et al., Gut 2013). Diagnosis of acute pancreatitis requires at least 2 of 3 criteria: (1) characteristic acute epigastric abdominal pain often radiating to the back, (2) serum lipase or amylase activity ≥ 3 times the upper limit of normal (ULN), and (3) characteristic findings of acute pancreatitis on contrast-enhanced CT, MRI, or transabdominal ultrasound.

The 2012 Revised Atlanta Classification stratifies severity into three tiers based on local/systemic complications and the duration of organ failure defined by a Modified Marshall Score ≥ 2:

• 1. Mild Acute Pancreatitis: No organ failure AND no local or systemic complications. Patients usually resolve within the first week and rarely require pancreatic CT imaging.
• 2. Moderately Severe Acute Pancreatitis: Presence of transient organ failure (resolving within ≤ 48 hours) AND/OR local complications (acute peripancreatic fluid collection [APFC], pancreatic pseudocyst, acute necrotic collection [ANC], or walled-off necrosis [WON]) or systemic exacerbation of pre-existing comorbidity (e.g., coronary artery disease or chronic lung disease) without persistent organ failure.
• 3. Severe Acute Pancreatitis: Defined strictly by persistent organ failure lasting > 48 hours (single or multiple organ failure), which carries a 30%–50% mortality rate.

Modified Marshall Scoring System for Organ Failure (Score ≥ 2 in Any System = Organ Failure)

Organ System	0 Points	1 Point	2 Points (Organ Failure Threshold)	3 Points	4 Points
Respiratory (PaO2 / FiO2)	> 400	301 – 400	201 – 300	101 – 200	≤ 100
Renal (Serum Creatinine, mg/dL)	< 1.4	1.4 – 1.8	1.9 – 3.6	3.7 – 4.9	> 4.9
Cardiovascular (Systolic BP, mmHg) (Off inotropic support)	> 90	< 90, fluid-responsive	< 90, not fluid-responsive	< 90, pH < 7.3	< 90, pH < 7.2

How Do BISAP, APACHE II, and the Balthazar CT Severity Index (CTSI) Serve as Inclusion Criteria in Acute Pancreatitis Trials?

In randomized controlled trials of acute pancreatitis therapeutics (such as goal-directed fluid resuscitation in the WATERFALL trial, enteral nutrition timing, and step-up necrosectomy trials capturing ePRO in clinical trials), protocols use a time-staged combination of clinical and radiological indices:

• Admission Screening (0–24 Hours — BISAP ≥ 2 or ≥ 3, SIRS, and APACHE II ≥ 8): Because pancreatic necrosis takes 72–96 hours to demarcate on CT, Phase II/III trials enroll patients with predicted severe acute pancreatitis at admission using BISAP ≥ 2 (or ≥ 3), persistent SIRS, blood urea nitrogen (BUN) trajectory, or APACHE II ≥ 8.
• Radiological Staging at ≥ 72 Hours — Balthazar CT Severity Index (CTSI, 0–10 Points) & Modified CTSI (Mortele et al., 2004): Performed 72 to 96 hours after symptom onset in patients who fail to improve, the Balthazar CTSI (Balthazar et al., 1990) sums two components on contrast-enhanced CT:
  1. Balthazar CT Grade of Pancreatic Inflammation (0 to 4 points): Grade A (normal pancreas = 0 pts), Grade B (focal or diffuse pancreatic enlargement = 1 pt), Grade C (pancreatic abnormalities with mild peripancreatic fat stranding = 2 pts), Grade D (single peripancreatic fluid collection = 3 pts), and Grade E (two or more fluid collections and/or retroperitoneal gas = 4 pts).
  2. Percentage of Pancreatic Parenchymal Necrosis (0 to 6 points): None (0 pts), ≤ 30% necrosis (+2 pts), 30% to 50% necrosis (+4 pts), and > 50% necrosis (+6 pts).

  Total Balthazar CTSI stratifies morphological severity into Mild (0–3 points; ~3% mortality), Moderate (4–6 points; ~6% mortality), and Severe (7–10 points; ~17% mortality and 92% complication rate). The Modified CTSI (Mortele et al., 2004; 0–10 points in 2-point increments) simplifies necrosis grading (0, ≤30% [+2], >30% [+4]) and adds +2 points for extrapancreatic complications (pleural effusion, ascites, vascular thrombosis, or GI involvement).

Frequently Asked Questions

Why has the 5-point bedside BISAP Score (BUN >25, Impaired mental status, SIRS, Age >60, Pleural effusion within 24 hours) largely replaced the 48-hour 11-item Ranson Criteria?

The 5-point BISAP Score (BUN >25 mg/dL, Impaired mental status with GCS <15, ≥2 SIRS criteria, Age >60 years, and Pleural effusion) can be calculated in the first 24 hours of admission regardless of pancreatitis etiology (with BISAP ≥3 predicting high risk of organ failure and mortality), whereas the 11-item Ranson Criteria require a 48-hour delay and separate gallstone vs. non-gallstone cutoffs.

How does the 2012 Revised Atlanta Classification stratify Acute Pancreatitis into Mild, Moderately Severe, and Severe using the Modified Marshall Organ Failure Score?

The 2012 Revised Atlanta Classification defines organ failure as a score of ≥2 in the respiratory (PaO2/FiO2 ≤300), renal (creatinine ≥1.9 mg/dL), or cardiovascular (SBP <90 mmHg unresponsive to fluid) systems on the Modified Marshall Scoring System. Mild acute pancreatitis has no organ failure or local complications; Moderately Severe has transient organ failure (resolving within ≤48 hours) and/or local complications; and Severe acute pancreatitis is defined by persistent organ failure lasting >48 hours.

How do BISAP, APACHE II, and the Balthazar CT Severity Index (CTSI) serve as inclusion criteria in acute pancreatitis trials?

In acute pancreatitis clinical trials, BISAP (≥2 or ≥3) and APACHE II (≥8) are used within the first 24 hours of admission to enroll patients at high risk of developing severe disease, while the 10-point Balthazar CT Severity Index (combining Balthazar CT Grades A–E [0–4 points] with pancreatic necrosis extent [0, 2, 4, or 6 points] on contrast-enhanced CT at ≥72 hours) quantifies structural necrosis and local complications.